Quadruple negative breast cancer

Triple Negative Breast Cancer Types detection and diagnosis

LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell

Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer. - Abstract - Europe PMC

Quadruple-responsive nanoparticle-mediated targeted combination chemotherapy for metastatic breast cancer - Nanoscale (RSC Publishing)

Frontiers Rewiring of the Endocrine Network in Triple-Negative Breast Cancer

MicroRNAs within the Basal-like signature of Quadruple Negative

PDF) Detection of miRNA regulatory effect on triple negative

Targeting Different Pathways Using Novel Combination Therapy in Triple Negative Breast Cancer

Microfluidic Systems and Breast Cancer Metastasis

AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature

IJMS, Free Full-Text

PDF] Quadruple-Negative Breast Cancer: An Uneven Playing Field

Enzalutamide Overcomes Dihydrotestosterone-Induced Chemoresistance in Triple- Negative Breast Cancer Cells via Apoptosis

BRE1121 Triple negative breast cancer with normal tissue array (most of triple negative TNBC), including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2), 112 cases/112 cores -